Aurobindo Pharma gets VAI classification from US regulator for Hyderabad unit
The inspection of Unit IV at Hyderabad, an injectable manufacturing formulation facility of the company, was conducted between…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
All efforts are being made to improve availability of medicines in India: Pharma Minister
The Minister also asked officers to maintain close coordination within themselves and with other concerned ministries to ensure…
Viravaxx AG and Medical University of Vienna collaborate on a project for immune diagnosis and…
In a clinical study, which has already received ethics approval and will start very soon, sera from convalescent COVID-19 patients…
Pills for the good health of pharma companies
Rohitashwa Prasad, Partner, JSA outlines the business strategies that pharma companies need to adopt for risk mitigation to deal…
Recent Advancement In Cancer Immunotherapy And Novel CAR-T Development
Virtual Bio Pharma Conclave 2020 - Accelerating BioPharma Innovation | Tue, Apr 21, 2020 | 3:00 PM - 4:00 PM IST
Cipla donates Rs 25 crores for COVID-19 relief fund
The company launched a spate of relief efforts for advance testing to safeguard healthcare providers and extend humanitarian care…
Pharmacists to maintain common flu, symptoms medicines record
The step is taken to keep tabs on patients/ persons having influenza-like fever, cold, throat infection, flu and similar symptoms…
Bristol Myers says Opdivo performs well in kidney, lung cancer trials
Opdivo is one of Bristol’s top-selling drugs, but sales of the drug have slowed in recent years as it has been eclipsed by Merck…
Novartis to test efficacy of old malaria drug against COVID-19
The company hopes to have data on its efficacy by June, a lead researcher for the trial told Reuters
CSIR backs development of a drug for patients suffering from Gram-negative sepsis
CSIR announced that it will initiate a randomised, blinded, two arms, active comparator-controlled clinical trial to evaluate the…